Items where authors include "Lezot, F."

Article

Cordova, L.A., Guilbaud, F., Amiaud, J. et al. (6 more authors) (2016) Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw. Journal of Craniomaxillofacial Surgery, 44 (9). pp. 1387-1394. ISSN 1010-5182

Heymann, D., Renema, N., Navet, B. et al. (2 more authors) (2016) RANK-RANKL signalling in cancers. Bioscience Reports, 36 (4). e00366. ISSN 1573-4935

Lezot, F., Chesneau, J., Navet, B. et al. (9 more authors) (2015) Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid. BONE, 73. pp. 51-59. ISSN 8756-3282

Gobin, B., Baud'Huin, M., Lamoureux, F. et al. (8 more authors) (2015) BYL719, a new alpha-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. International Journal of Cancer, 136 (4). pp. 784-796. ISSN 0020-7136

Gamblin, A-L., Brennan, M.A., Renaud, A. et al. (5 more authors) (2014) Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: The local implication of osteoclasts and macrophages. Biomaterials, 35 (36). pp. 9660-9667. ISSN 0142-9612

Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282

Baud'Huin, M., Charrier, C., Bougras, G. et al. (4 more authors) (2012) Proteoglycans and osteolysis. Proteoglycans, 836. pp. 323-337. ISSN 1064-3745

Lezot, F., Thomas, B.L., Blin-Wakkach, C. et al. (8 more authors) (2010) Dlx Homeobox Gene Family Expression in Osteoclasts. Journal of Cellular Physiology, 223 (3). pp. 779-787. ISSN 0021-9541